PA
PCRX icon

Perceptive Advisors’s Pacira BioSciences PCRX Stock Holding History

Perceptive Advisors’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-50
Closed -$4K – 179
2015
Q2 		$4K Buy
+50
New +$3.94K ﹤0.01% 173
2014
Q2 		– Sell
-2,000
Closed -$139K – 135
2014
Q1 		$139K Buy
+2,000
New +$136K 0.01% 115
2013
Q4 		– Sell
-272,034
Closed -$13.1M – 129
2013
Q3 		$13.1M Buy
+272,034
New +$9.91M 1.06% 21

Other funds holding PCRX

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
MCM
Marsico Capital Management Denver, Colorado $3.83B AUM 63.68% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $9.69B AUM 55.7% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
HCM
Hoplite Capital Management New York $15.1M AUM 27.41% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Perceptive Advisors's PCRX Position: Q3 2015 in Review

Perceptive Advisors sold out of Pacira BioSciences (PCRX) in Q3 2015, closing a stake of 50 shares — an estimated $4K sold.

Perceptive Advisors first reported a position in PCRX in Q3 2013 and held it in 3 quarters. The position peaked at $13.1M in Q3 2013. 177 funds tracked by Wall St. Rank hold PCRX as of Q3 2015.

  • Perceptive Advisors reported no remaining Pacira BioSciences position as of Q3 2015 after selling out during the quarter.
  • Perceptive Advisors sold 50 Pacira BioSciences shares in Q3 2015, an estimated $4K.
  • Perceptive Advisors first reported a position in Pacira BioSciences in Q3 2013 and held it in 3 quarters.
  • Perceptive Advisors's Pacira BioSciences position peaked at $13.1M in Q3 2013.
  • 177 funds tracked by Wall St. Rank held Pacira BioSciences as of Q3 2015.

Based on Perceptive Advisors's 13F filing for Q3 2015, filed 16 Nov 2015.